Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB vs SACITUZUMAB GOVITECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUCAPARIB vs SACITUZUMAB GOVITECAN: Safety Overview

Metric RUCAPARIB SACITUZUMAB GOVITECAN
Total FAERS Reports 434 1,261
Deaths Reported 50 353
Death Rate 11.5% 28.0%
Hospitalizations 310 530
Average Patient Age 64.3 yrs 57.3 yrs
% Female Patients 69.5% 89.0%
Manufacturer N/A Gilead Sciences, Inc.
Route N/A INTRAVENOUS